USD
$0.00
(0.00%
)At Close (As of Sep 5, 2025)
$65.00M
Market Cap
-
P/E Ratio
-0.26
EPS
$1.88
52 Week High
$0.17
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | $56M |
Total Revenue | $71M |
Cost Of Revenue | $16M |
Costof Goods And Services Sold | $16M |
Operating Income | -$34M |
Selling General And Administrative | $80M |
Research And Development | $9.6M |
Operating Expenses | $90M |
Investment Income Net | - |
Net Interest Income | -$8.3M |
Interest Income | - |
Interest Expense | $8.3M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $5.5M |
Income Before Tax | -$43M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$43M |
Comprehensive Income Net Of Tax | - |
Ebit | -$35M |
Ebitda | -$29M |
Net Income | -$43M |
Field | Value (USD) |
---|---|
Total Assets | $97M |
Total Current Assets | $39M |
Cash And Cash Equivalents At Carrying Value | $26M |
Cash And Short Term Investments | $26M |
Inventory | - |
Current Net Receivables | $8.6M |
Total Non Current Assets | $58M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $5.9M |
Intangible Assets Excluding Goodwill | $5.9M |
Goodwill | $15M |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $4.6M |
Other Non Current Assets | - |
Total Liabilities | $76M |
Total Current Liabilities | $14M |
Current Accounts Payable | $2.2M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.5M |
Total Non Current Liabilities | $62M |
Capital Lease Obligations | $26M |
Long Term Debt | $36M |
Current Long Term Debt | $21K |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $62M |
Other Current Liabilities | $9.9M |
Other Non Current Liabilities | $815K |
Total Shareholder Equity | $21M |
Treasury Stock | - |
Retained Earnings | -$462M |
Common Stock | $145K |
Common Stock Shares Outstanding | $130M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$49M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $5.5M |
Capital Expenditures | $3.2M |
Change In Receivables | - |
Change In Inventory | $22K |
Profit Loss | - |
Cashflow From Investment | -$3.4M |
Cashflow From Financing | $52M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $625K |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$43M |
Field | Value (USD) |
---|---|
Gross Profit | $56M |
Total Revenue | $71M |
Cost Of Revenue | $16M |
Costof Goods And Services Sold | $16M |
Operating Income | -$34M |
Selling General And Administrative | $80M |
Research And Development | $9.6M |
Operating Expenses | $90M |
Investment Income Net | - |
Net Interest Income | -$8.3M |
Interest Income | - |
Interest Expense | $8.3M |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $5.5M |
Income Before Tax | -$43M |
Income Tax Expense | - |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$43M |
Comprehensive Income Net Of Tax | - |
Ebit | -$35M |
Ebitda | -$29M |
Net Income | -$43M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company is headquartered in Boulder, Colorado.